Evidence map›Paper›PMID 21697242›Full record

ArticleAmerican journal of physiology. Renal physiology2011

Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC).

Tengis S Pavlov, Daria V Ilatovskaya, Vladislav Levchenko, David L Mattson, Richard J Roman, Alexander Staruschenko

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Multi-Target Approaches in Metabolic Syndrome.Frontiers in pharmacology · 2020
    Review
  11. Review
  12. Article
  13. Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2018
    Article
  14. 20-HETE: Hypertension and Beyond.Hypertension (Dallas, Tex. : 1979) · 2018
    Review
  15. Review
  16. Article
  17. Article
  18. Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.Journal of the American Society of Nephrology : JASN · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tengis S PavlovDept. of Physiology, Medical College of Wisconsin, Milwaukee, 53226, USA.
Daria V Ilatovskaya
Vladislav Levchenko
David L Mattson
Richard J Roman
Alexander Staruschenko
Institute of Cytology · RUMedical College of Wisconsin · USUniversity of Mississippi Medical Center · US

Funding

VASOPRESSIN SECRETION AND CARDIOVASCULAR FUNCTIONP01HL029587 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI COWLEY, ALLEN W · 1985 to 2012
$24.1M
20-HETE-TGF-beta in Hypertension-Induced Renal InjuryR37HL036279 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI ROMAN, RICHARD J. · 2005 to 2014
$4.0M
VASA RECTA HEMODYNAMICS IN GENETIC HYPERTENSIONR01HL036279 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI ROMAN, RICHARD J. · 1986 to 2004
$1.3M
NHLBI NIH HHS HL 29587NHLBI NIH HHS HL36279NHLBI NIH HHS R37 HL036279
6 · The paper itself

Abstract

Sodium reabsorption via the epithelial Na(+) channel (ENaC) in the aldosterone-sensitive distal nephron plays a central role in the regulation of body fluid volume. Previous studies have indicated that arachidonic acid (AA) and its metabolite 11,12-EET but not other regioisomers of EETs inhibit ENaC activity in the collecting duct. The goal of this study was to investigate the endogenous metabolism of AA in cultured mpkCCD(c14) principal cells and the effects of these metabolites on ENaC activity. Liquid chromatography/mass spectrometry analysis of the mpkCCD(c14) cells indicated that these cells produce prostaglandins, 8,9-EET, 11,12-EET, 14,15-EET, 5-HETE, 12/8-HETE, and 15-HETE, but not 20-HETE. Single-channel patch-clamp experiments revealed that 8,9-EET, 14,15-EET, and 11,12-EET all decrease ENaC activity. Neither 5-, 12-, nor 15-HETE had any effect on ENaC activity. Diclofenac and ibuprofen, inhibitors of cyclooxygenase, decreased transepithelial Na(+) transport in the mpkCCD(c14) cells. Inhibition of cytochrome P-450 (CYP450) with MS-PPOH activated ENaC-mediated sodium transport when cells were pretreated with AA and diclofenac. Coexpression of CYP2C8, but not CYP4A10, with ENaC in Chinese hamster ovary cells significantly decreased ENaC activity in whole-cell experiments, whereas 11,12-EET mimicked this effect. Thus both endogenously formed EETs and their exogenous application decrease ENaC activity. Downregulation of ENaC activity by overexpression of CYP2C8 was PKA dependent and was prevented by myristoylated PKI treatment. Biotinylation experiments and single-channel analysis revealed that long-term treatment with 11,12-EET and overexpression of CYP2C8 decreased the number of channels in the membrane. In contrast, the acute inhibitory effects are mediated by a decrease in the open probability of the ENaC. We conclude that 11,12-EET, 8,9-EET, and 14,15-EET are endogenously formed eicosanoids that modulate ENaC activity in the collecting duct.

Indexed as

8,11,14-Eicosatrienoic AcidAnimalsArachidonic AcidCell LineCHO CellsCricetinaeCricetulusCytochrome P-450 Enzyme SystemDiclofenacEpithelial Sodium ChannelsFemaleIbuprofenKidney Tubules, CollectingMiceModels, AnimalOvary11,12-epoxy-5,8,14-eicosatrienoic acid14,15-epoxy-5,8,11-eicosatrienoic acid8,11,14-Eicosatrienoic Acid8,9-epoxyeicosatrienoic acidArachidonic Acidcytochrome P-450 CYP2C subfamilyCytochrome P-450 Enzyme SystemDiclofenacEpithelial Sodium ChannelsIbuprofen

Identifiers

PMID21697242
PMCPMC3174560
OpenAlexW2155510119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.